Gene upregulated in cancers of the prostate
CA 2388709 C · Owner: Afar, Daniel E. H. · Inventors: Mitchell, Steve Chappell; Hubert, Rene S.; Jakobovits, Aya
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a novel protein designated 20P2H8 which shares homology with several heterogenous nuclear ribonucleoproteins (hnRNPs). A full length approximately 3600 bp 20P2H8 cDNA (SEQ ID NO:10), encoding a 517 amino acid open reading frame (SEQ ID NO:2) is provided herein.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 26, 2000 and granted March 13, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 26, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 26, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.